EBITDA Growth
-100.63%
TTM · Period ending:
MED EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-100.63%period ending
Latest reported-100.63%period ending
MED TTM EBITDA YoY % (-726.67% → -100.63%)
Year-over-year change
High-resolution chart · PNG
MED ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 197.688% | |
| 142.9165% | |
| 125.628% | |
| 117.6203% | |
| 22.7123% | |
| -1,280.2548% | |
| -460.6122% | |
| -107.4863% | |
| 44.4326% | |
| 95.3687% | |
| 82.6241% | |
| -258.8235% | |
| -726.6667% |